Correction to: Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis
Ann Hematol
.
2024 Oct;103(10):4349-4350.
doi: 10.1007/s00277-024-05940-4.
Authors
Keiki Nagaharu
1
2
,
Eiko Ohya
3
4
,
Yoko Edahiro
5
,
Yoshinori Hashimoto
6
,
Tomoki Ito
7
,
Akihiko Gotoh
8
,
Mika Nakamae
9
,
Fumihiko Kimura
10
,
Michiaki Koike
11
,
Keita Kirito
12
,
Hideho Wada
13
,
Kensuke Usuki
14
,
Takayuki Tanaka
6
,
Takehiko Mori
15
16
,
Satoshi Wakita
17
,
Toshiki I Saito
18
,
Akiko M Saito
18
,
Kazuya Shimoda
19
,
Toshiro Kurokawa
20
,
Akihiro Tomita
21
,
Hitoshi Kiyoi
22
,
Koichi Akashi
23
,
Itaru Matsumura
24
,
Katsuto Takenaka
25
,
Norio Komatsu
5
26
27
28
,
Kohshi Ohishi
29
,
Isao Tawara
3
,
Yuka Sugimoto
3
Affiliations
1
Department of Hematology and Oncology, Mie University Graduate School of Medicine, Mie Prefecture, Japan. keiki-nagaharu@med.mie-u.ac.jp.
2
Lund University Cancer Center, Lund University, Lund, Sweden. keiki-nagaharu@med.mie-u.ac.jp.
3
Department of Hematology and Oncology, Mie University Graduate School of Medicine, Mie Prefecture, Japan.
4
Department of Hematology, Matsusaka General Hospital, Matsusaka, Japan.
5
Department of Hematology, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-ku, Tokyo, Japan.
6
Department of Hematology, Tottori Prefectural Central Hospital, Tottori, Japan.
7
First Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
8
Department of Hematology, Tokyo Medical University, Tokyo, Japan.
9
Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
10
Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
11
Department of Hematology, Juntendo University Shizuoka Hospital, Shizuoka, Japan.
12
Department of Hematology and Oncology, University of Yamanashi, Yamanashi, Japan.
13
Department of Hematology, Kawasaki Medical School, Okayama, Japan.
14
Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
15
Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
16
Department of Hematology, Tokyo Medical and Dental University, Tokyo, Japan.
17
Division of Hematology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
18
Clinical Research Center, NHO Nagoya Medical Center, Aichi, Japan.
19
Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
20
Department of Hematology, Toyama Red Cross Hospital, Toyama, Japan.
21
Department of Hematology, Fujita Health University School of Medicine, Aichi, Japan.
22
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Aichi, Japan.
23
Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
24
Division of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka, Japan.
25
Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime, Japan.
26
Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.
27
Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
28
PharmaEssentia Japan KK, Tokyo, Japan.
29
Department of Transfusion Medicine and Cell Therapy, Mie University Hospital, Mie Prefecture, Japan.
PMID:
39167184
DOI:
10.1007/s00277-024-05940-4
No abstract available
Publication types
Published Erratum